| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 03/04/1998 | CN1175260A Induction of cytotoxic t -lymphocyte responses |
| 03/04/1998 | CN1174836A Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 03/04/1998 | CN1174833A Phenyl substituted alkenocarboxylic guanidine, preparation method, application as medicine or diagnostic agent adn medicine containing it |
| 03/04/1998 | CN1174709A Traditional Chinese set prescription for curing gastrointestinal tract disease and gynopathy |
| 03/03/1998 | US5723485 Analgesic, antiinflammatory agents |
| 03/03/1998 | US5723484 Benzopyran compounds as 5-HT2C receptor antagonists |
| 03/03/1998 | US5723441 Method of treating renal disease by administering IGF-I and IGFBP-3 |
| 02/28/1998 | CA2213814A1 Naphthalene compounds, intermediates, formulations, and methods |
| 02/26/1998 | WO1998007853A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | WO1998007422A1 Therapeutic treatment for sexual dysfunctions |
| 02/26/1998 | WO1998007420A1 Neuropeptide-y ligands |
| 02/26/1998 | CA2268051A1 Neuropeptide-y ligands |
| 02/26/1998 | CA2263875A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2263556A1 Therapeutic treatment for sexual dysfunctions |
| 02/25/1998 | EP0825260A2 Arginase II |
| 02/25/1998 | EP0825178A1 Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them |
| 02/25/1998 | EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque |
| 02/25/1998 | EP0824530A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 02/25/1998 | EP0824519A1 Beta-adrenergic agonists |
| 02/25/1998 | CN1174508A Improvement in or relating to endometrial function |
| 02/25/1998 | CN1174493A Amelioration of human erectile dysfunction by treatment with iNOS, and related NOS agents |
| 02/24/1998 | CA2154103C Treatment of mucous membrane disease, trauma or condition and for the relief of pain |
| 02/24/1998 | CA2086919C Process for the production of unsaturated 17.alpha.-cyanomethyl -17.beta. hydroxy steroids |
| 02/19/1998 | WO1998006848A1 GnRH-LEUKOTOXIN CHIMERAS |
| 02/19/1998 | WO1998006846A1 Human induced tumor protein |
| 02/19/1998 | WO1998006844A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12) |
| 02/19/1998 | WO1998006722A1 Thienopyrimidines |
| 02/19/1998 | WO1998006427A2 Cross-protective equine herpesvirus preparations and method of making and using the same |
| 02/19/1998 | DE19632423A1 Thienopyrimidine Thienopyrimidines |
| 02/19/1998 | CA2263165A1 Human induced tumor protein |
| 02/19/1998 | CA2263143A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12) |
| 02/19/1998 | CA2262524A1 Gnrh-leukotoxin chimeras |
| 02/18/1998 | EP0823906A1 Piperazino derivatives as neurokinin antagonists |
| 02/18/1998 | EP0823895A1 Fatty acid esters as bioactive compounds |
| 02/18/1998 | EP0823889A1 1,3-propane diol derivatives as bioactive compounds |
| 02/18/1998 | EP0609217B1 Dry starch-iodine pharmaceutical formulations |
| 02/18/1998 | EP0561939B1 Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy |
| 02/17/1998 | US5719278 Tricyclic benzazepine vasopressin antagonists |
| 02/17/1998 | US5719180 Chroman derivatives having vitamin E-like activities |
| 02/17/1998 | US5719173 Administering a benzimidazole carboxylate |
| 02/17/1998 | US5719169 Substituted benzoylguanidines, their use as a medicament or diagnostic, and medicament containing them |
| 02/17/1998 | US5719165 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism |
| 02/17/1998 | US5719138 Contacting with a dicitrate cyclic diester |
| 02/17/1998 | US5719121 Administering balhimycin to monogastric or polygastric animal as growth promoter |
| 02/17/1998 | US5718917 PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction |
| 02/17/1998 | US5718865 Shaping a graunlated alum and plasticizer mixture |
| 02/17/1998 | CA1339679C Reduced size lhrh analogs |
| 02/12/1998 | WO1998005792A2 A novel human leptin receptor gene-related protein |
| 02/12/1998 | WO1998005782A1 Testis-specific insulin homolog polypeptides |
| 02/12/1998 | WO1998005780A2 Voltage-gated calcium channel antagonist and methods |
| 02/12/1998 | WO1998005776A2 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | WO1998005323A2 Method of regulating the female reproductive system through angiogenesis inhibitors |
| 02/12/1998 | WO1998005293A2 Method of regulating the female reproductive system through angiogenesis inhibitors |
| 02/12/1998 | CA2262753A1 Voltage-gated calcium channel antagonist and methods |
| 02/12/1998 | CA2262535A1 Method of regulating the female reproductive system through angiogenesis inhibitors |
| 02/12/1998 | CA2262399A1 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | CA2262223A1 Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof |
| 02/12/1998 | CA2261783A1 1,2-diarylindole as cox-2 inhibitors |
| 02/12/1998 | CA2261573A1 A novel human leptin receptor gene-related protein |
| 02/11/1998 | EP0823437A2 8-Substituted B-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators |
| 02/11/1998 | EP0822942A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation |
| 02/11/1998 | EP0822826A1 Nitrosylated neuropeptides |
| 02/11/1998 | EP0822814A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 02/11/1998 | EP0822757A1 Stress regulator for animals |
| 02/11/1998 | EP0624164B1 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 02/11/1998 | CN1173132A Dihydropyrimidines and uses thereof |
| 02/10/1998 | US5717088 Method of making steroid derivatives for the treatment of prostatic hypertrophy |
| 02/10/1998 | US5716994 Plant extracts |
| 02/10/1998 | US5716986 Lipoxygenase inhibitors |
| 02/10/1998 | US5716959 Administering substituted piperazines having hydroxy- or amino-alkyl groups on one nitrogen and carboxylic, phosphoric or sulfonic alkyl groups on the other nitrogen, for treatment of cancer and autoimmune diseases |
| 02/10/1998 | US5716777 Regulation of meiosis using sterols |
| 02/06/1998 | CA2212204A1 8-substituted b-nor-6-thiaequilenin compounds having activity as selective estrogen receptor modulators |
| 02/05/1998 | WO1998004581A1 Dolastatin pentapeptide derivatives and their use as antitumor agents |
| 02/05/1998 | WO1998004269A1 Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen |
| 02/05/1998 | WO1998004268A1 Oral contraceptive |
| 02/05/1998 | WO1998004265A1 Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen |
| 02/05/1998 | CA2261748A1 Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen |
| 02/05/1998 | CA2261689A1 Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen |
| 02/05/1998 | CA2261687A1 Oral contraceptive |
| 02/04/1998 | EP0822190A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/04/1998 | EP0822185A1 B-3-adrenergic agonists as antidiabetic and antiobesity agents |
| 02/04/1998 | EP0821960A1 Use of xanthine derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821952A1 Use of isoxazole and crotonic acid amide derivatives for the modulation of apoptosis |
| 02/04/1998 | EP0821585A1 USE OF $g(a) 1L? AGONISTS IN THE TREATMENT OF INCONTINENCE |
| 02/04/1998 | EP0655916B1 Transdermal application agent containing 3-keto-desogestrel |
| 02/03/1998 | US5714508 Inhibitors of angiotensin ii |
| 02/03/1998 | US5714486 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 02/03/1998 | US5714473 Chemotherapy; mixture with alkali metal citrate |
| 02/03/1998 | US5714381 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 02/03/1998 | CA1339660C Derivatives of cyclohexane |
| 01/31/1998 | CA2211866A1 .beta.-adrenergic agonists |
| 01/29/1998 | WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 01/29/1998 | WO1998003059A1 Galanin |
| 01/28/1998 | EP0820991A2 Cycloalkyl derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
| 01/28/1998 | EP0820988A2 Imino derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
| 01/28/1998 | EP0820445A1 Inhibitors of farnesyl-protein transferase |
| 01/28/1998 | EP0820441A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| 01/28/1998 | EP0820426A1 SUBSTITUTED DIBENZ[a,f]AZULENES AND METHODS OF PREPARATION |
| 01/28/1998 | EP0820302A1 Combination compositions containing benazepril or benazeprilat and valsartan |
| 01/28/1998 | EP0820294A1 Use of nitric oxide-releasing agents to treat impotency |